Beacon Capital Management LLC (Tennessee)’s Sarepta Therapeutics SRPT Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-49	Closed	-$838	–	888
2025 Q2	$838	Hold	49	–	–	﹤0.01%	1000
2025 Q1	$3.13K	Sell	49 -354	-88%	-$37.3K	﹤0.01%	862
2024 Q4	$49K	Hold	403	–	–	0.01%	304
2024 Q3	$50.3K	Hold	403	–	–	0.01%	323
2024 Q2	$63.7K	Hold	403	–	–	0.01%	248
2024 Q1	$52.2K	Hold	403	–	–	0.01%	289
2023 Q4	$48.9K	Hold	403	–	–	0.01%	226
2023 Q3	$46.2K	Hold	403	–	–	0.01%	258
2023 Q2	$46.2K	Hold	403	–	–	0.01%	258
2023 Q1	$55.5K	Sell	403 -149	-27%	-$19.3K	0.02%	204
2022 Q4	$71.5K	Sell	552 -89	-14%	-$10.3K	0.02%	181
2022 Q3	$48K	Hold	641	–	–	0.02%	211
2022 Q2	$50K	Hold	641	–	–	0.01%	245
2022 Q1	$50K	Buy	+641	New	+$49.1K	0.01%	245

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s SRPT Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 49 shares — an estimated $838 sold.

Beacon Capital Management LLC (Tennessee) first reported a position in SRPT in Q1 2022 and held it in 14 quarters. The position peaked at $71.5K in Q4 2022. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 49 Sarepta Therapeutics shares in Q3 2025, an estimated $838.
Beacon Capital Management LLC (Tennessee) first reported a position in Sarepta Therapeutics in Q1 2022 and held it in 14 quarters.
Beacon Capital Management LLC (Tennessee)'s Sarepta Therapeutics position peaked at $71.5K in Q4 2022.
320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.